EMPAGLIFLOZIN REDUCES MORTALITY IN PATIENTS WITH TYPE 2 DIABETES AND A HISTORY OF LEFT VENTRICULAR HYPERTROPHY: A SUB-ANALYSIS OF THE EMPA-REG OUTCOME TRIAL
Canadian Journal of Cardiology(2018)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要
Canadian Journal of Cardiology(2018)